In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Promentis Pharmaceuticals, Inc.

http://www.promentispharma.com/

Latest From Promentis Pharmaceuticals, Inc.

Finance Watch: Second Quarter Begins With Solid Base For Biopharma VC, Shaky Ground For Acorda

First quarter VC investments in biopharma set high expectations for the second quarter; Acorda cuts jobs after patent litigation defeat, plus other strategic realignments; no new US IPOs, but Europe has three; and notable follow-on offerings.

Financing StartUps and SMEs

Execs On The Move, September 2013

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device

Start-Up Execs On The Move, September 2013

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

BioPharmaceutical Medical Device

Selected Start-Ups (02/2009)

In Vivo briefly describes these recently founded companies: Axikin Pharmaceuticals, Garnet BioTherapeutics, Medimetriks Pharmaceuticals, Nexomics Biosciences, OrthAlign and Promentis Pharmaceuticals.

See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register